What Tar Heel Capital does

Tar Heel Capital is a Warsaw-based private equity firm founded in 1998 by Grzegorz Bielowicki, managing a series of closed-end buyout funds (THC I through THC IV) targeting mid-sized Polish companies with minimum EBITDA of PLN 5 million or revenues of PLN 50 million. The firm invests primarily via majority stake acquisitions (typically 60–100%) with founders retained as co-investors, deploying €10–25 million per transaction with co-investment reach up to €50 million. Across four fund vintages totaling approximately €270 million in commitments, THC has completed 23 portfolio investments exceeding €500 million of capital deployment and executed exits generating roughly 2 billion PLN in sale proceeds, with documented IRR above 20% and notable outcomes including an 8.9x Cash-on-Cash return on the Rockfin exit.

The firm operates two business lines: THC Private Equity, the core buyout franchise focused on manufacturing, healthcare, and B2B services in Poland (with active platforms including the Dentity dental network at 160 million PLN in 2024 revenues and Med-Gastr in gastroenterology); and Tar Heel Capital Pathfinder, a Szczecin-based venture builder targeting technology opportunities in esports, big data, cloud computing, fintech, and martech. THC sources capital exclusively from European and American private financial institutions (LPs with combined assets exceeding €100 billion in THC IV) through direct institutional relationships, with no public institutions in the LP base. Revenue is generated through the standard 2-and-20 PE model — 1.5–2% management fees on committed capital and 20% carried interest on profits above the hurdle. Distribution is restricted to qualified investors under Polish AIF regulations, and the firm maintains a small team (11–50 employees) across its Warsaw headquarters and Szczecin office.

Name

Tar Heel Capital

Legal name

Tar Heel Capital Sp. z o. o.

Website

https://tarheelcap.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Tar Heel Capital is a Warsaw-based private equity firm founded in 1998, managing four fund vintages (THC I–IV, ~€270M total committed) that invest in mid-sized Polish companies across healthcare, manufacturing, and B2B services, plus a venture-building subsidiary targeting global technology opportunities.

Ownership category

akta.pro rank

Product category

Private Equity Fund Management

NAICS

Funds, Trusts, and Other Financial Vehicles (525)

SIC

Finance Services (6199)

akta.pro primary industry

HoldCo / Permanent Capital ETA (FSANALAE)

Keywords

• Private equity funds
• Buyout investments
• Growth capital
• Venture building
• Portfolio management

Headquarters

HQ city

Warszawa

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Private Equity Fund Management: Tar Heel Capital generates returns through management fees (typically 1.5-2% of committed capital) and carried interest (20% of profits above hurdle rate) from its managed private equity funds. The firm has a strong track record with IRR consistently exceeding 20% across fund generations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Tar Heel Capital manages private equity funds (THC I through THC IV) that acquire majority stakes (typically 60–75%) in Polish mid-market companies with EBITDA of at least PLN 5 million or revenue of PLN 50 million+, deploying EUR 10–50 million per transaction. The firm partners with founders and management, supports strategic planning and operational scaling, and exits via strategic sales, IPOs, or secondary PE transactions within a 5–7 year horizon. A separate subsidiary, THC Pathfinder, operates as a venture builder co-creating global technology businesses.

Product overview

Tar Heel Capital operates as a private equity firm with a family of investment funds. The core offering is THC Private Equity, which provides capital for development to Polish medium-sized companies in manufacturing, B2B services, and healthcare sectors. The subsidiary THC Pathfinder operates as a venture builder for technology businesses in esports, big data, cloud computing, fintech, and martech. The fund family spans multiple generations: THC I (1998, 30M EUR), THC II (2012, 50M EUR), THC III (2019, 70M EUR), and THC IV (2024, 120M EUR). The investment strategy focuses on acquiring significant majority stakes while partnering with entrepreneurs, supporting strategic planning, and helping companies achieve market leadership positions.

Differentiator

Problem solved

Functional benefit

Brands

• THC Private Equity: The main private equity arm of Tar Heel Capital, investing in medium-sized Polish companies across manufacturing, B2B services, and healthcare sectors.
• Tar Heel Capital Pathfinder
• Dentity
• TOMMA

Products and services

• THC Private Equity Private equity fund product for majority-stake buyouts of Polish mid-market companies (minimum PLN 5 million EBITDA / PLN 50 million revenue), deploying EUR 10–50 million per transaction with a 5–7 year exit horizon. For Polish mid-market companies and their founders, as well as European/American institutional LPs.
• THC IV Fund Fourth-generation private equity fund with record EUR 120 million capitalization, targeting Polish medium-sized enterprises with focus on succession-planning situations. Typical deal size EUR 10–25 million, expandable to EUR 50 million with co-investors.
• THC III Fund Third-generation PE fund launched in 2019 with EUR 70 million capitalization, planned to allocate over EUR 100 million of own funds for acquisitions and development of Polish companies across manufacturing, B2B services, and healthcare.
• THC II Fund Second-generation PE fund raised in 2012 with EUR 50 million in capital, investing approximately EUR 100 million (including debt financing) across 9 Polish companies.
• THC I Fund First PE fund launched in 1998 by Grzegorz Bielowicki with EUR 30 million; invested in 9 companies including LiveChat Software (later IPO'd on Warsaw Stock Exchange in 2014).
• Tar Heel Capital Pathfinder Venture-building subsidiary co-creating global technology businesses; current focus areas include esports, big data, cloud computing, fintech, and martech. For early-stage technology founders.

Quantifiable outcome

• Portfolio companies on average triple their revenues and profits during THC investment period
• +3 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators12 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Bridgepoint: Global private equity firm with significant CEE presence including Poland. Comparable to Tar Heel Capital in mid-market focus but operates at substantially larger AUM with broader geographic reach and deeper resources.
• CVC Capital Partners: Global private equity firm with significant European operations including Poland. While much larger, CVC competes for similar mid-to-large Polish opportunities and has overlapping sector exposure in healthcare, manufacturing, and B2B services.
• Advent International: Global private equity firm with active investments in Poland and CEE. Comparable sector overlap (healthcare, business services, industrial) but operates at much larger scale than Tar Heel Capital, competing for similar Polish opportunities.

Direct peers

• Mid Europa Partners: Leading private equity firm focused on Central and Eastern Europe with over €5 billion AUM. Directly comparable to Tar Heel Capital as both invest in Polish/CEE mid-market opportunities across multiple sectors with majority stake acquisitions and similar exit horizons.
• Abris Capital Partners: CEE-focused private equity firm investing in mid-market companies across Poland, Romania, Hungary and other CEE countries. Comparable to Tar Heel Capital in fund size, sector focus, and mid-market buyout approach.
• Enterprise Investors: One of the largest PE/VC firms in Poland and CEE, established in 1990. Comparable to Tar Heel Capital as both target Polish mid-market companies for growth capital and ownership transitions, with similar fund structures and sector exposure.
• Argus Capital Group: Independent investment firm focused on Polish mid-market private equity. Directly comparable to Tar Heel Capital as both target similar deal sizes and Polish companies seeking growth capital and succession solutions.
• Innova Capital: Polish private equity firm managing mid-market investments across Poland and CEE. Directly comparable to Tar Heel Capital in size, focus on Polish mid-market companies, and approach to majority stake acquisitions with management partnership.
• Cornerstone Partners: CEE-focused private equity firm with strong Polish presence investing in mid-market companies. Comparable to Tar Heel Capital in target company size, investment approach, and regional focus.
• Resource Partners: Polish private equity firm focused on mid-market buyouts and growth capital in Poland. Directly comparable to Tar Heel Capital's investment size, sector focus (manufacturing, services, healthcare), and operating model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/tar-heel-capital-private-equity
• Facebookfacebook.com/TarHeelCapital

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A15 records

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tar Heel Capital